GLPHubglpresearchhub.com
Read-only archive. GLP Research Hub is a static community record — nothing here is for sale, no account is needed, and no vote you cast is counted. Why?
Archived. This submission is more than a year old. Votes and new comments are closed, and some of the advice in it may have been superseded — check the community wiki for the current version.
0
c/retatrutide·posted 2 years ago by u/reta_and_regret

[Results] 66 weeks, 24kg, and triple agonist was the hard part

Results

66 weeks, 24kg, and triple agonist was the hard part. Full detail below, and I have tried to keep the editorialising out of it.

Since the title puts numbers in the shop window: 66 weeks and 24kg.

Went up slowly, deliberately, because everything on this board says the escalation is where trouble lives. Uneventful so far and I am not going to pretend that is a finding.

Independent purity testing on this compound is thin compared with the older molecules, simply because fewer members have paid for it. Fewer results means wider uncertainty, not a verdict.

If somebody has the same thing measured a different way, post it next to mine and we will see whether they agree.

0 up / 0 down43% upvoted9 commentsid 1bbsh120 Nov 2023

9 comments

9 in this archive, depth 4

best — the order this archive was captured in

u/injection_site_iris6 points·2 years ago

Where the evidence actually stands, since every thread here assumes a different answer.

Phase 2 reported a large mean body weight change at 48 weeks across a few hundred participants with a slow, protocol-driven escalation. The effect size was striking. The confidence intervals were wide, the population was small, and the duration was under a year.

Phase 3 is running. Until it reports, everything else — including the ranking arguments this board loves — is extrapolation from a small study. That is not a criticism of the compound; it is a description of the evidence.

replysharereportpermalink
u/kofi_balogun4 points·2 years ago

This. The phase 2 result was genuinely large and it was also 48 weeks in a few hundred people.

replysharereportpermalink
u/tired_ledger_notes3 points·2 years ago

not approved anywhere, which is the single most important fact in this board

replysharereportpermalink
u/liver_enzyme_liz1 point·2 years ago

Agreed, and the framing that helps is: this is a phase 2 compound with phase 3 running. Everything else is inference.

replysharereportpermalink
u/reta_and_regretOP-30 points·2 years ago

Are you tracking heart rate at all?

replysharereportpermalink
u/incretin_ivypharmacology3 points·2 years ago

What is the source for that figure — the published paper or a summary of it?

replysharereportpermalink
u/reta_and_regretMOD2 points·2 years ago

Standing reminder in every thread here: unapproved compound, research material is not for human use, nothing on this board is medical advice.

replysharereportpermalink
u/naomi_erdogan1 point·2 years ago

Same read. The energy-expenditure mechanism is the interesting bit and it is not established in humans at scale.

replysharereportpermalink
u/rekha_vestergaard1 point·2 years ago

Cosigning the escalation point. Almost every difficult report on this board is from somebody who went up quickly.

replysharereportpermalink
About c/retatrutide

Retatrutide: GIP/GLP-1/glucagon triple agonism, the TRIUMPH programme, and the fact that most people discussing it are handling research-grade material with no human-use approval anywhere. Dose-response, heart-rate signal, and the unusually steep phase-2 weight curves get argued about here weekly.

65kmembers
130submissions
Sep 2023created
submissions / month, last year
Sponsored

PeptideMeter Analytics

Independent testing plus vendor-level trend data. Community-funded, unaffiliated.

peptidemeter.com
c/retatrutide rules
  1. Retatrutide is not approved anywhere for human use. Posts must not read as usage instructions.
  2. Phase 2 numbers are not maintenance numbers. Cite the trial and the dose arm.
  3. Heart-rate and dose-escalation reports need actual measurements, not impressions.
  4. Independent community. Nobody here sells anything, and anyone who tries is banned.
  5. Not medical advice. Describe what you did; never prescribe to a stranger.
  6. Claims need evidence. Batch numbers, dated screenshots, independent test reports, or a citation.
  7. No referral links, discount codes or affiliate URLs. Permanent ban, no appeal.
  8. No contact handles, wallet addresses or tracking numbers — they identify people.
  9. Be recognisably decent. Disagree hard, insult nobody.
Moderators
Volunteers. Unpaid, unaffiliated, and reachable through modmail only.
Before you read on

Several compounds discussed on GLP Research Hub are sold for research use only and are not approved for human use anywhere. Nothing here is medical advice and none of it is written by your clinician. If a post reads like an instruction, treat it as a description of what one stranger did.